Join Shares and AJ Bell for an evening of investment inspiration and get to meet the decision-makers behind some of the UKs fastest growing listed companies.
The event on Wednesday 18 September 2019 in London will include:
An opportunity for you to talk directly with the directors and ask your questions about the companies core strengths and their short and long-term business strategy
Meet fellow investors and share your investing experience
Complimentary drinks and snacks
More about the companies presenting:
Mercia Asset Management (MERC) (Formerly Mercia Technologies) The change of name reflects the evolution of the Groups core competencies as a proactive, regionally-focused specialist asset manager.
Open Orphan (ORPH) a European-focussed, rare and orphan drug consulting services platform. The Company will target the fragmented orphan drug services market in Europe.
ReNeuron Group (RENE) ReNeuron Group is a leading, clinical-stage stem cell business. Our primary objective is the development of novel stem cell therapies targeting areas of significant unmet or poorly met medical need.
+ More to be announced...
Who Should Attend
The evening is a perfect opportunity for existing shareholders or potential investors to hear from the directors running the companies, being the individuals best placed to explain the strategy and opportunity for investors.
Evening timings
18.00
Registration and coffee
18.30
Presentations
Dr. Mark Payton, CEO - Mercia Asset Management (MERC)
Michael Hunt, CFO - ReNeuron Group (RENE)
Martin Glanfield, CFO - Mercia Asset Management (MERC)
Maurice Treacy, CCO - Open Orphan (ORPH)
20.00
Drinks reception and canapés
21.00
Close
Venue
Sponsored by
Featured Companies
